June 18, 2015
On behalf of the Global Alliance for Patient Access I participated in this week’s International Nonproprietary Names (INN) Biological Qualifier (BQ) Comments Review: Front Page Meeting with Stakeholders, held at the World Health Organization Headquarters in Geneva, Switzerland.
June 16, 2015
With new legislation on oral parity in both the U.S. House of Representatives and the U.S. Senate, disparity in insurance coverage between infusion and oral chemotherapy may soon be a problem of the past.
June 12, 2015
Crackdowns on so-called pill mills – pain management centers where financially motivated physicians over prescribe opioid pain medications – are designed to reduce abuse and overdoses.
June 10, 2015
Seniors who depend upon high-cost medications may soon have a better shot at affording them.
June 5, 2015
For preemies facing respiratory syncytial virus (RSV), risk factors matter – and gestational age alone cannot determine whether infants need preventative treatment.
June 3, 2015
The Golden State is making bold strides toward improving health care access and safety for its citizens. Earlier this month, California’s state health care exchange announced a cap on out-of-pocket costs for prescription medications.
May 28, 2015
Insurers have a new strategy for reducing the costs of injectable and intravenous prescription drugs: switching these medication from patients’ medical benefit to their prescription drug coverage.
May 26, 2015
While states across the country grapple with the Medicaid population’s need for costly hepatitis C cures, Connecticut has taken a bold stand for patient access.
May 21, 2015
Though newly finalized guidance from the FDA has provided some clarity on biosimilarity, crucial questions about the regulation of biosimilars remain unanswered.
May 18, 2015
When it comes to sophisticated and powerful medications like biologics, the details matter.
